PLPPR1

Chr 9

phospholipid phosphatase related 1

Also known as: LPPR1, PRG-3

This gene encodes a member of the plasticity-related gene family that mediates lipid phosphate phosphatase activity in neurons and is involved in neuronal plasticity, with strong expression in the developing brain. Mutations in PLPPR1 cause autosomal recessive spastic paraplegia with intellectual disability and seizures, typically presenting in early childhood. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.5), consistent with its role in critical neurodevelopmental processes.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.50
Clinical SummaryPLPPR1
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.57) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
17 unique Pathogenic / Likely Pathogenic· 34 VUS of 56 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.50LOEUF
pLI 0.566
Z-score 2.94
OE 0.19 (0.090.50)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.44Z-score
OE missense 0.71 (0.610.81)
135 obs / 191.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.19 (0.090.50)
00.351.4
Missense OE0.71 (0.610.81)
00.61.4
Synonymous OE1.08
01.21.6
LoF obs/exp: 3 / 15.5Missense obs/exp: 135 / 191.0Syn Z: -0.54
DN
0.7230th %ile
GOF
0.6442th %ile
LOF
0.3940th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

56 submitted variants in ClinVar

Classification Summary

Pathogenic17
VUS34
17
Pathogenic
34
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
17
0
17
Likely Pathogenic
0
0
0
0
0
VUS
0
34
0
0
34
Likely Benign
0
0
0
0
0
Benign
0
0
0
0
0
Total03417051

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PLPPR1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 2 results · since 2015Search PubMed ↗